Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3801–3850 of 76264
As of the Closing Date, Christopher D. Levendos has resigned from his position as the Company's Executive Vice President and Chief Operating Officer—Fiber to pursue an opportunity with Zayo.
Mr. Norwood replaces Ryan D. Campbell, who was acting Chief Financial Officer and will continue as President, Worldwide Construction & Forestry and Power Systems for the Company.
On April 29, 2026, Peter K. Shea notified the Company of his decision to resign as a member of the Board of Directors (the "Board"), including from his service on the Company’s Audit Committee.
On April 30, 2026, the Company appointed each of Mr. Thomas D. Davis, the Company’s Chief Executive Officer, and Mr. Craig Pettit to serve as members of the Board to fill the vacancies created by the resignations of Messrs. Peter Shea and Read.
Also, on April 29, 2026, Randolph C. Read notified the Company of his decision to resign as a member of the Board.
On April 30, 2026, the Company appointed each of Mr. Thomas D. Davis, the Company’s Chief Executive Officer, and Mr. Craig Pettit to serve as members of the Board to fill the vacancies created by the resignations of Messrs. Peter Shea and Read.
promoted the Company’s Vice President and Deputy General Counsel, Jennifer Lankford, as the Company’s next Senior Vice President, General Counsel and Corporate Secretary effective upon Mr. Wolfson’s retirement
the Senior Vice President, General Counsel and Corporate Secretary of Cracker Barrel Old Country Store, Inc. (the “Company”), Richard Wolfson, notified the Company of his intent to retire on May 5, 2026
the Board approved changing the term of Mr. Levin’s appointment from a fixed term to a month-to-month arrangement, to continue until otherwise determined by the Board
On May 1, 2026, the Board of Directors (the “Board”) of Stock Yards Bancorp, Inc. (the “Company”) appointed Scott P. Davis to serve as a member of the Board, effective May 1, 2026, in connection with the completion of the Company’s previously announced acquisition of Field & Main Bancorp, Inc.
Effective simultaneously with this appointment, Mr. Davis was appointed to serve as a director of Stock Yards Bank & Trust Company (the “Bank”), the Company’s principal banking subsidiary, and to serve on the Bank’s Trust Committee.
On April 27, 2026, Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, informed Acadia Pharmaceuticals Inc. (the “Company”) of her planned retirement.
On April 27, 2026, the Board appointed Dr. Shao-Lee Lin as the Company’s President and Chief Executive Officer and as a member of the Board, effective as of her commencement of employment with the Company, which began on April 30, 2026
On April 27, 2026, the Board appointed Dr. Shao-Lee Lin as the Company’s President and Chief Executive Officer and as a member of the Board, effective as of her commencement of employment with the Company, which began on April 30, 2026
Dr. Lin will succeed Lucinda Warren whose resignation as Interim President and Chief Executive Officer was effective as of April 30, 2026
On April 29, 2026, the Board of Directors (the “Board”) of Flowco Holdings Inc. (the “Company”) appointed J. Hardy Murchison, effective April 29, 2026, to fill a vacancy on the Board.
Thomas M. “Roe” Patterson and C. Richard Vermillion ceased serving as directors of the Company
Jeremy D. Thigpen were elected
Mr. Prejean commenced service as Chairman of the Board while continuing to serve as the Company’s President and Chief Executive Officer
Ira H. Green, Jr., Daniel J. Kimes and Jeremy D. Thigpen were elected
Daniel J. Kimes and Jeremy D. Thigpen were elected
C. Richard Vermillion ceased serving as directors of the Company
On May 1, 2026, the Company announced that the Board of Directors of the Company (the “Board”) approved the appointment of Sharon Price John as Chief Executive Officer and President of the Company and a member of the Board, effective June 15, 2026
On May 1, 2026, the Company announced that the Board of Directors of the Company (the “Board”) approved the appointment of Sharon Price John as Chief Executive Officer and President of the Company and a member of the Board, effective June 15, 2026
Michael H. Rogers was appointed to serve as Chief Financial Officer and Treasurer of the Company, effective June 1, 2026.
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
James Gertler, Bruce Bernstein, Dan Galpern, Kendrick Meek, Brian Daly and Robert S. Mancini (collectively with Philip Kassin, Jeffrey Douglas Epstein and Stuart Ellman, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025
the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026
On the same date, Ben Landen was appointed as the Chief Executive Officer by the Company’s board of directors, effective immediately.
On April 28, 2026, Long Long notified the board of directors of Archimedes Tech SPAC Partners III Co. (the “Company”) of his resignation as Chief Executive Officer of the Company, effective immediately.
Andrew Gundlach was appointed Executive Chairman of the Board and resigned as President and Chief Executive Officer of the Company, effective April 29, 2026
Marcello Padula, the Company’s currently serving Chief Operating Officer, was appointed to serve as Chief Executive Officer of the Company, effective April 29, 2026
Andrew Gundlach was appointed Executive Chairman of the Board and resigned as President and Chief Executive Officer of the Company, effective April 29, 2026
the engagement of Jeffrey T. Varsalone as Chief Restructuring Officer of the Company and its subsidiaries was terminated, effective immediately.
Mr. Carhart’s departure was not as a result of any dispute with the Company.
Effective as of May 1, 2026 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Craig Christensen as the Company’s Interim Chief Financial Officer, Interim Treasurer and Interim Secretary, to succeed Ryan Carhart
Effective as of May 1, 2026 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Craig Christensen as the Company’s Interim Chief Financial Officer, Interim Treasurer and Interim Secretary, to succeed Ryan Carhart, the former Chief Financial Officer, Treasurer and Secretary of the Company, who notified the Company on April 28, 2026 that he is leaving the Company to pursue another professional opportunity effective as of the Effective Date.
Following receipt of formal notice on April 27, 2026, Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc. (the “Company”), effective as of April 30, 2026, as part of a business transition and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices.
the Board of Directors appointed Mr. Xiaomin Chen as Chief Executive Officer, director and Chairman of the Board of the Company, effective as of April 28, 2026.
The Company and Mr. Yi Lu, the Company’s Chief Executive Officer, director and Chairman of the Board, have mutually agreed that a leadership transition is necessary and in the best interests of the Company.
On April 28, 2026, the Board of Directors of Owens Corning (the “Company”) promoted Todd W. Fister to Executive Vice President, Chief Financial and Operating Officer, effective as of May 1, 2026.
Effective as of May 8, 2026, Christi Powitzky resigned as the Chief Compliance Officer of Teucrium Trading, LLC (the “Sponsor”), Sponsor of Teucrium Agricultural Fund, Teucrium Wheat Fund, Teucrium Soybean Fund, Teucrium Sugar Fund, Teucrium Corn Fund, and 7RCC Spot Bitcoin and Carbon Credit Futures ETF (collectively, the “Funds”), each a series of the Teucrium Commodity Trust (the “Registrant”).
Effective May 11, 2026, Brian T. MacKenzie has been appointed Chief Compliance Officer of the Sponsor.
Kenneth E. Wolf the President of the Company who was formerly the Company's Chief Financial Officer, will act as the Company's Principal Financial and Principal Accounting Officer.
Michael E. Fortin has given his notice of resignation as the Chief Financial Officer of the Company effective May 15, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.